MEDSCAPE MEDICAL NEWS by Larry Hand                                                                        Dec. 9, 2014

Airport exit screening in West Africa and entry screening in the United States have identified few persons potentially infected with Ebola virus, according to an article published online December 9 in the Centers for Disease Control and Prevention (CDC) publication Morbidity and Mortality Weekly Report.

 Number of travelers arriving from Guinea, Liberia, and Sierra Leone who were screened for Ebola at US airports, by state and county of destination (October 11 - November 10, 2014). Source: CDC

Of 80,000 travelers who have departed from West Africa since Ebola-specific screening began, 1993 people have been screened on arrival at one of five US airports. Of those, 86 passengers were referred to the CDC public health officers; only seven have shown symptoms and been referred for evaluation. None eventually wound up with an Ebola diagnosis.

A few months ago the U.S. Centers for Disease Control and Prevention predicted that up to 1.4 million people in Liberia and Sierra Leone could become infected with Ebola by mid-January. In a recent address to the Senate, CDC director Tom Frieden said that worst-case scenario would not pan out.

That is partly because health care workers in the Ebola hot zone are engaged in a battle to contain the epidemic. It is also because of assumptions about human and viral behavior that are built into the mathematical models used to predict the spread of infectious diseases. Assumptions are inherent in these models. “You take islands of data from different places and build bridges of assumptions that link up all these islands,” says Martin Meltzer, senior health economist at the CDC. Meltzer’s model, which predicted the 1.4 million infections in Liberia and Sierra Leone, worked on the assumption that things would not improve. “Our forecasts are based on the idea that nothing will change,” he says.

REUTERS                                                                                                                    Dec. 9, 2014

CHICAGO -- The U.S. Department of Health and Human Services on Tuesday offered liability protections to drugmakers rushing to develop Ebola vaccines and urged other countries to follow suit.

Health and Human Services (HHS) Secretary Sylvia Burwell made the announcement as part of the Public Readiness and Emergency Preparedness (PREP) Act in a move aimed at encouraging the development and availability of experimental Ebola vaccines.

The declaration provides immunity under U.S. law against legal claims related to the manufacturing, testing, development, distribution, and administration of three vaccines for the Ebola virus. However, it does not provide immunity for a claim brought in a court outside the United States...

Read full story

http://www.reuters.com/article/2014/12/09/us-health-ebola-vaccine-idUSKBN0JN1S920141209

Archived Video - Watch the meeting held on Tuesday, December 9, 2014, from 1:00 to 2:00 p.m. (ET).

Speakers: Nancy A. Aossey, President and Chief Executive Officer, International Medical Corps

Laurie Garrett, Senior Fellow for Global Health, Council on Foreign Relations; Author, Ebola: Story of an Outbreak

David Nabarro, Special Envoy on Ebola, United Nations

Presider: Richard E. Besser, Chief Health and Medical Editor, ABC News

Experts recently returned from trips to West Africa with medical teams operating Ebola-treatment units there discuss the situation on the ground and developments in the international response to the crisis.

CLICK HERE - Council on Foreign Relations - Ebola Update: Assessment From Africa

CLICK HERE - YouTube - Council on Foreign Relations - Ebola Update: Assessment From Africa